EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Invasive Candidiasis in Liver Transplant Recipients Undergoing Antifungal Prophylaxis

Luiz Felipe de Abreu Guimarães, Larissa de Oliveira Pereira, Tainara Moreira Curcio, Claudia Cristina Tavares de Sousa, Samanta Teixeira Basto, Damares Szrajbman, Eduardo de Souza Martins Fernandes, Guilherme Santoro-Lopes

Transplantation Proceedings · 2026

DOI: 10.1016/j.transproceed.2026.05.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Luiz Felipe de Abreu Guimarães und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Transplante Hepático, Hospital Adventista Silvestre, Rio de Janeiro, Brazil; Hospital Universitário Clementino Fraga Filho, Universidade …. Hauptthemen laut MEDLINE: Liver Transplantation, Antifungal Agents, Candidiasis, Invasive. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Invasive candidiasis (IC) is the most frequent invasive fungal infection (IFI) affecting liver transplant (LT) recipients. Antifungal prophylaxis (AP) effectively reduces the incidence IFI after LT. However, a considerable proportion of LT recipients undergoing AP are still affected by IC. OBJECTIVES: To assess the incidence and factors associated with IC in high-risk LT recipients undergoing AP. PATIENTS AND METHODS: Retrospective single-center study including high-risk LT recipients undergoing AP between 2015 and 2020. The primary outcome was the occurrence of IC within the first 90 days after LT. Secondary outcomes included mortality within 30 days of diagnosis of IC and the occurrence of other IFI within 90 days after LT. The basic prophylactic regimen was fluconazole 200 mg/d, with micafungin being an alternative option. RESULTS: There were 10 cases (5.8%) of IC among 171 high-risk recipients who started AP. Most cases were caused by non-albicans Candida spp. The 30-day mortality rate was 40%. Only 1 case (0.6%) of another IFI (disseminated cryptococcosis) was diagnosed during the study period. IC was more frequent among Black patients (p=0.02), after reoperation (p = .036), and in recipients with a higher count of risk factors for IFI (p = .061). Oppositely, IC was less frequent in patients with a pre-transplant diagnosis of hepatocellular carcinoma (p = .065). CONCLUSION: IC occurred in 5.8% of LT recipients undergoing AP and was associated with high mortality. The predictive factors for IC identified in this study may inform the decision to start empirical antifungal therapy in high-risk LT recipients undergoing AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationAntifungal AgentsCandidiasis, InvasiveHumansRetrospective StudiesFemaleMiddle AgedMaleRisk FactorsMicafunginAgedAdultIncidenceFluconazole

Substanzen

Antifungal AgentsMicafunginFluconazole

Autor:innen und Institutionen

  • Programa de Transplante Hepático, Hospital Adventista Silvestre, Rio de Janeiro, Brazil; Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil. Electronic address: luizfelipeag@gm…
  • Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil.
  • Programa de Transplante Hepático, Hospital Adventista Silvestre, Rio de Janeiro, Brazil.
  • Programa de Transplante Hepático, Hospital Adventista Silvestre, Rio de Janeiro, Brazil; Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Brazil.

Zitieren

APA

de Abreu Guimarães, L. F., Pereira, L. O., Curcio, T. M., de Sousa, C. C. T., Basto, S. T., Szrajbman, D., Fernandes, E. S. M., & Santoro-Lopes, G. (2026). Invasive Candidiasis in Liver Transplant Recipients Undergoing Antifungal Prophylaxis. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.05.006

Vancouver

de Abreu Guimarães LF, Pereira LO, Curcio TM, de Sousa CCT, Basto ST, Szrajbman D, et al. Invasive Candidiasis in Liver Transplant Recipients Undergoing Antifungal Prophylaxis. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.05.006

BibTeX
@article{deAbreuGuimares2026,
  author = {de Abreu Guimarães, Luiz Felipe and Pereira, Larissa de Oliveira and Curcio, Tainara Moreira and de Sousa, Claudia Cristina Tavares and Basto, Samanta Teixeira and Szrajbman, Damares and Fernandes, Eduardo de Souza Martins and Santoro-Lopes, Guilherme},
  title = {Invasive Candidiasis in Liver Transplant Recipients Undergoing Antifungal Prophylaxis},
  journal = {Transplantation Proceedings},
  year = {2026},
  doi = {10.1016/j.transproceed.2026.05.006}
}
Kostenlos starten →